Estimating economic efficiency of preclinical diagnostics of Parkinson disease with cost-utility approach

Neurodegenerative diseases, Parkinson disease among them, set challenges to modern societies both in terms of premature deaths and resources spent on treatment of the diseases. At that, preventive care and early diagnostics in particular are potential directions towards higher economic efficiency of healthcare interventions in this area.  https://doi.org/10.3897/popecon.4.e59949